MARKET

DTIL

DTIL

Precision Biosciences
NASDAQ
6.31
-0.02
-0.32%
After Hours: 6.31 0 0.00% 19:30 10/02 EDT
OPEN
6.42
PREV CLOSE
6.33
HIGH
6.44
LOW
6.20
VOLUME
292.95K
TURNOVER
--
52 WEEK HIGH
9.62
52 WEEK LOW
3.530
MARKET CAP
174.17M
P/E (TTM)
-2.2530
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DTIL last week (0921-0925)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Precision BioSciences (DTIL)
TipRanks · 5d ago
Precision BioSciences (DTIL) Receives a Rating Update from a Top Analyst
TipRanks · 09/22 09:45
Weekly Report: what happened at DTIL last week (0914-0918)?
Weekly Report · 09/21 09:47
Weekly Report: what happened at DTIL last week (0907-0911)?
Weekly Report · 09/14 09:50
Weekly Report: what happened at DTIL last week (0831-0904)?
Weekly Report · 09/07 09:46
Weekly Report: what happened at DTIL last week (0824-0828)?
Weekly Report · 08/31 09:50
iECURE Says Updated OTC-HOPE Low-Dose Data Showed 74% Reduction In Annualized Hyperammonemic Crises, 57% Reduction In Hyperammonemic Events; Completes Phase 1/2 Dosing Across All Three Cohorts
Benzinga · 08/27 12:07
More
About DTIL
Precision BioSciences, Inc. is a clinical-stage gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Company’s pipeline comprises in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform is used to develop in vivo gene editing therapies for gene edits, including gene insertion, elimination, and excision. The Company's in vivo gene editing pipeline programs include PBGENE-HBV, PBGENE-3243, PBGENE-DMD, PBGENE-LIVER, PBGENE-CNS, PBGENE-NVS and iECURE-OTC. PBGENE-HBV is an in vivo gene editing program which targets and eliminates covalently closed circular DNA (cccDNA), the sole source of viral replication, leading to sustained loss of pre-genomic RNA (pgRNA), the precursor for hepatitis B virus (HBV) DNA. ELIMINATE-B is designed to be a curative treatment for chronic hepatitis B infection.

Webull offers Precision BioSciences Inc stock information, including NASDAQ: DTIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DTIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DTIL stock methods without spending real money on the virtual paper trading platform.